Management of monoamniotic twin pregnancies: Where, when, how?


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 04 05 2021
revised: 26 08 2021
accepted: 20 09 2021
pubmed: 27 9 2021
medline: 13 1 2022
entrez: 26 9 2021
Statut: ppublish

Résumé

Management difficulties for monochorionic monoamniotic (MCMA) twin pregnancy reflect the absence of high-quality research into optimal types of monitoring, essential as MCMA twins have a high risk of intrauterine and neonatal death with perinatal mortality. D'Antonio et al's meta-analysis and the MonoMono study published in 2019, investigated the impact of monitoring location, out- or in-patient, of MCMA pregnancies and concluded that no specific management location is associated with improvement in prognosis. To evaluate the optimal timing for delivery of MCMA pregnancies, Van Mieghem and Chitrit carried out retrospective studies comparing gestational age of intrauterine death and risk of neonatal complication. The crossover point between the propective risk of intrauterine fetal death and neonatal complication was found at 32,33 weeks of gestation (WG), in accordance with American College of Obstetricians and Gynecologists and Royal College of Obstetricians and Gynaecologists recommendations but inclusion of complicated pregnancies and analysis of fetuses individually may be regarded as a bias. The majority of studies of MCMA pregnancies focused on elective scheduled cesareans, with only rare retrospective studies reporting on vaginal delivery. Of these, two recent studies carried out by French teams suggest that vaginal deliveries may be as safe as cesarean births for MCMA twin pregnancies when specific criteria are met. In summary, concerning MCMA pregnancies, prognosis is not found to improve with inpatient management, optimal timing for delivery is at approximately 33 GW and vaginal delivery should not be excluded.

Identifiants

pubmed: 34563720
pii: S2468-7847(21)00169-0
doi: 10.1016/j.jogoh.2021.102232
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102232

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

Amélie Delabaere (A)

Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand 63000, France; CNRS-UMR 6602, Institut Pascal, Axe TGI, Clermont Auvergne University, Clermont-Ferrand, France. Electronic address: adelabaere@chu-clermontferrand.fr.

Pamela Bouchet (P)

Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand 63000, France.

Ferras Sendy (F)

Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand 63000, France.

Fanny Petillon (F)

Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand 63000, France.

Denis Gallot (D)

Obstetric Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand 63000, France; Translational approach to epithelial injury and repair' team, CNRS, Inserm, GReD, Auvergne University, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH